BioSpecifics Tech (BSTC) Posts Surprising Q4 Profit

March 11, 2011 7:05 AM EST
BioSpecifics Technologies Corp. (Nasdaq: BSTC) reported Q4 EPS of $0.02, $0.06 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.38 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings